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branches seem to follow a curved path surprisinglywell, unless
the renal artery was implanted into the wall of a surgical graft
at a prior operation and fixed in place by subsequent scarring.
Fenestrations have a theoretic advantage over cuffs when
part of the aortic lumen is small enough to constrict the
perigraft space. Nevertheless, it is nowmore than 4 years since
we last used a fenestration as a branch attachment point in a
thoracoabdominal stent graft. During this time, we have
treatedmany patients in whom some part of the visceral aortic
lumenwas narrower than 25mm. Themost extreme example
was a case of thoracoabdominal aneurysm complicating
chronic type B dissection in which the true lumen measured
only 12mm 25mmpreoperatively. Although fenestrations
have been used successfully as attachment sites for the
branches of a thoracoabdominal stent graft,2-7 we prefer cuffs
for two reasons. First, branch placement may be impossible in
the presence of any mismatch between the position of a
fenestration and the position of the target artery. Conse-
quently, any attempt at standardized off-the-shelf use of a
fenestrated stent graft14 is limited to a several sizes fit most
approach. Second, unlike the caudally oriented, stent re-
enforced, self-expanding branch of a cuffed stent graft, the
transversely oriented, balloon-expanded branch of a fenes-
trated stent graft cannot bear much load. The cuffed stent
graftmay be subject to large caudally directed forces, due to its
taper, but we have never seen one migrate, and we have never
seen its branches collapse or fall out, as branches sometimes do
when attached to the narrow rim of a fenestration.3
Our initial exploration of the standardized approach was
prompted by two patients: one died from rupture while wait-
ing for a CSG; the other made a quick recovery after repair of
a ruptured thoracoabdominal aortic aneurysm using a stent
graft that had been made for someone else (with the approval
of the institutional review board). A standard cuff-bearing
stent graft is definitely a good thing to have in stock for
off-the-shelf use in urgent cases, even if one does not adopt its
wholesale use in elective cases. The standard multibranched
stent graft has less obvious but equally important advantages
relating to the manufacture, preclinical testing, clinical study,
and regulatory approval of a device for widespread use. It is
expensive to make and difficult to study a family of devices
with multiple alternative features. Another custom-made de-
vice, the fenestrated stent graft, has been in a state of regula-
tory limbo for years. Meanwhile, surgeons in the United
States, with patients in need of multibranched thoracoab-
dominal stent grafts, have little choice but to add cuffs and
fenestrations themselves.15
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Dr R. Scott Mitchell (Palo Alto, Calif). Dr Chuter, congratu- ost of us doing these extensive operations realize that we exact a
ignificant toll on these elderly patients, with probably fewer than 50%
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September 2011668 Chuter et alof survivors returning to their previous lifestyle. We would all wel-
come a less-invasive alternative; which leads me to my questions.
1. What is the next step? Do you think this device is ready for a
prospective trial aimed toward FDA approval?
2. Since you are one of the visionaries who are helping to shape the
future, do you envision this as the treatment of choice which
anatomic factors constitute the more challenging patient?
3. Last, chronic dissections with branch vessels arising from both
true and false lumens have precluded endovascular methods.
Do you foresee the means to manage these complex patients?
Again, my thanks to the Program Committee for allowing me
to discuss this interesting manuscript.
Dr Timothy A. M. Chuter.
1. The development of a standard stent graft facilitates both
preclinical and clinical testing of device performance, which
should speed progress toward FDA approval of branched stent
graft technology. It is much harder to study a family of custom-
ized devices, as evidenced by the long delayed approval of the
fenestrated Zenith stent graft.
2. Some patients are indeed easier to treat than others, and some-
times we need to do a little preparatory work in the form of an
iliofemoral bypass, balloon angioplasty of a stenotic renal artery,
or carotid-subclavian bypass. However, few patients lack the
anatomic substrate for repair. It is not so much a question of
who we can treat, but of who we should treat. For example, we
still have too little long-term data to recommend multi-
branched endovascular repair in good-risk patients, especially
those with type IV TAAAs for whom conventional open repair
has low rates of death and paraplegia. We are also hesitant torecommend this form of repair in women who seem to have
higher complication rates than men, although the recent devel-
opment of a low-profile (18F) version of the systemmay help to
eliminate the gender gap. Men, on the other, hand do well with
multibranched thoracoabdominal endovascular repair, regard-
less of aneurysm extent. We have used the current technique to
treat over 40 men without a single case of death or paraplegia.
Putting all this together, endovascular repair is the preferred
treatment for a sick old man with a large type II TAAA.
. The multibranched endovascular repair of TAAA complicat-
ing chronic dissection is difficult for several reasons. First,
branches that originate from the false lumen may be inacces-
sible from the true lumen where the stent graft lies. We have
occasionally fenestrated the septum between one lumen and
the other, but the necessary maneuvers were neither easy nor
risk free. Second, a compressed true lumen has the potential
to restrict the perigraft space and complicate branch inser-
tion. Third, common iliac artery involvement makes it diffi-
cult to preserve both internal iliac arteries, which are impor-
tant sources of collateral flow to the spine. Fourth, distal arch
involvement makes it difficult to preserve the left subclavian
artery, another important source of collateral flow to the
spine. All of these problems are surmountable, but we believe
that multibranched endovascular repair of a chronic thora-
coabdominal aortic dissection is not yet ready for widespread
use. Fortunately, isolated (unbranched) endovascular repair
of the proximal descending thoracic aorta is often enough to
induce false lumen thrombosis in the area where the aneu-
rysm is widest, thereby preventing further dilatation and
reducing the medium-term risk of rupture.
